Attention Deficit Hyperactivity Disorder (ADHD). Hyperkinetic disorders
Conditions
Interventions
Intervention 1: folic acid (5mg/day). Intervention 2: Placebo.
Treatment - Drugs
Placebo
folic acid (5mg/day)
Sponsors
Vice chancellor for research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 19 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) according to DSM-IV diagnostic criteria; children and adolescents aged 7 to 19 years old. Exclusion criteria: Self reported an allergic reaction to folic acid; kidney disease; being on dialysis; infection; anemia; epilepsy; taking medications such as phenytoin, methotrexate, nitrofurantoin, tetracycline barbiturates such as Phenobarbital, primidone; lack of providing written informed consent for participation; a diagnosed psychotic disorder; extensive use of nutritional folic acid supplements within the previous 3 months; behavior therapy or any other psychotherapy in the last three months or during this study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD rating questionnaire. Timepoint: evey 30 days. Method of measurement: parent report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Overt Aggression Scale. Timepoint: evey 30 days. Method of measurement: parent report. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed